Trademark Overview
On Monday, January 26, 2026, a trademark application was filed for CBX-250 with the United States Patent and Trademark Office. The USPTO has given the CBX-250 trademark a serial number of 99615554. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, January 26, 2026. This trademark is owned by Crossbow Therapeutics, Inc.. The CBX-250 trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment and prevention of cancer and immunological diseases and disordersocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary...
